Comparison of Volumetric Measurement Method With Region of Interest Drawing Method for Liver Fat Quantification
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to evaluate the feasibility of measuring liver fat using the volumetric measurement method (Fatvol) by comparing it with the conventional 27-regions of interest drawing method (Fatroi). Materials and Methods: This retrospective study included 67 patients who underwent liver magnetic resonance imaging with fat quantification in August or September 2020. Two experienced abdominal radiologists measured the proton density fat fraction (PDFF) of the liver using the mDIXON-Quant sequence for each of two methods. The PDFF was measured twice with each method at intervals of at least 4 weeks to avoid recall bias. Measurement times were recorded. The intra-class correlation coefficient (ICC) was calculated for intra-exam repeatability, inter-reviewer reproducibility, and inter-exam agreement. Results: Measurement times for Fatvol were significantly shorter than for Fatroi. Measurement times for Fatroi and Fatvol, respectively, for reviewer A were 209.4 ± 55.1 s and 137.2 ± 51.5 s in session 1, and 180.9 ± 37.3 s and 127.0 ± 46.1 s in session 2. For reviewer B, the times were 190.7 ± 30.1 s and 74.8 ± 27.4 s in session 1, and 174.6 ± 21.8 s and 64.1 ± 17.5 s in session 2. In all cases, p < 0.001. The mean PDFF values were 7.2% ± 6.4% and 7.2% ± 6.5% (sessions 1 and 2, respectively) for Fatroi and 7.4% ± 6.0% and 7.3% ± 6.1% for Fatvol for reviewer A. For reviewer B, they were 7.1% ± 6.6% and 7.1% ± 6.6% for Fatroi and 7.4% ± 5.8% and 7.4% ± 5.8% for Fatvol. The ICCs between measurement methods (0.998 and 0.995 for reviewers A and B, respectively), for Fatvol within each reviewer (0.999 and 1.000 in sessions 1 and 2, respectively), and between reviewers (0.999) were excellent. Conclusion: The measurement time could be significantly reduced using Fatvol compared to Fatroi while maintaining the consistency of the liver fat measurement values.
Abstract
Purpose: This study aimed to evaluate the feasibility of measuring liver fat using the volumetric measurement method (Fatvol) by comparing it with the conventional 27-regions of interest drawing method (Fatroi). Materials and Methods: This retrospective study included 67 patients who underwent liver magnetic resonance imaging with fat quantification in August or September 2020. Two experienced abdominal radiologists measured the proton density fat fraction (PDFF) of the liver using the mDIXON-Quant sequence for each of two methods. The PDFF was measured twice with each method at intervals of at least 4 weeks to avoid recall bias. Measurement times were recorded. The intra-class correlation coefficient (ICC) was calculated for intra-exam repeatability, inter-reviewer reproducibility, and inter-exam agreement. Results: Measurement times for Fatvol were significantly shorter than for Fatroi. Measurement times for Fatroi and Fatvol, respectively, for reviewer A were 209.4 ± 55.1 s and 137.2 ± 51.5 s in session 1, and 180.9 ± 37.3 s and 127.0 ± 46.1 s in session 2. For reviewer B, the times were 190.7 ± 30.1 s and 74.8 ± 27.4 s in session 1, and 174.6 ± 21.8 s and 64.1 ± 17.5 s in session 2. In all cases, p < 0.001. The mean PDFF values were 7.2% ± 6.4% and 7.2% ± 6.5% (sessions 1 and 2, respectively) for Fatroi and 7.4% ± 6.0% and 7.3% ± 6.1% for Fatvol for reviewer A. For reviewer B, they were 7.1% ± 6.6% and 7.1% ± 6.6% for Fatroi and 7.4% ± 5.8% and 7.4% ± 5.8% for Fatvol. The ICCs between measurement methods (0.998 and 0.995 for reviewers A and B, respectively), for Fatvol within each reviewer (0.999 and 1.000 in sessions 1 and 2, respectively), and between reviewers (0.999) were excellent. Conclusion: The measurement time could be significantly reduced using Fatvol compared to Fatroi while maintaining the consistency of the liver fat measurement values.
참고문헌 (31)
- Perumpail BJ, "Clinical epidemiology and disease burden of nonalcoholic fatty liver disease", World J Gastroenterol, 23, pp.8263~8276 (2017)
- Angulo P, "Obesity and nonalcoholic fatty liver disease", Nutr Rev, 65(6 Pt 2), pp.S57~S63 (2007)
- Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
- Adams LA, "NAFLD as a risk factor for the development of diabetes and the metabolic syndrome : an eleven-year follow-up study", Am J Gastroenterol, 104, pp.861~867 (2009)
- Schwenzer NF, "Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance", J Hepatol, 51, pp.433~445 (2009)
- Reimer KC, "New drugs for NAFLD : lessons from basic models to the clinic", Hepatol Int, 14, pp.8~23 (2020)
- Ratziu V, "Sampling variability of liver biopsy in nonalcoholic fatty liver disease", Gastroenterology, 128, pp.1898~1906 (2005)
- Rockey DC, "Liver biopsy", Hepatology, 49, pp.1017~1044 (2009)
- Boyd A, "Medical liver biopsy : background, indications, procedure and histopathology", Frontline Gastroenterol, 11, pp.40~47 (2020)
- Machado MV, "Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal", J Hepatol, 58, pp.1007~1019 (2013)
- Han A, "Assessment of hepatic steatosis in nonalcoholic fatty liver disease by using quantitative US", Radiology, 295, pp.106~113 (2020)
- Ferraioli G, "US attenuation for liver fat quantification : an AIUM-RSNA QIBA pulseecho quantitative ultrasound initiative", Radiology, 302, pp.495~506 (2022)
- Fazel R, "Exposure to low-dose ionizing radiation from medical imaging procedures", N Engl J Med, 361, pp.849~857 (2009)
- Starekova J, "Liver fat quantification : where do we stand?", Abdom Radiol(NY), 45, pp.3386~3399 (2020)
- Starekova J, "Quantification of liver fat content with CT and MRI : state of the art", Radiology, 301, pp.250~262 (2021)
- Sirli R, "Controlled attenuation parameter for quantification of steatosis : which cut-offs to use?", Can J Gastroenterol Hepatol, 2021, pp.6662760~ (2021)
- Reeder SB, "Proton density fat-fraction : a standardized MR-based biomarker of tissue fat concentration", J Magn Reson Imaging, 36, pp.1011~1014 (2012)
- Yokoo T, "Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging : a meta-analysis", Radiology, 286, pp.486~498 (2018)
- Reeder SB, "Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy", J Magn Reson Imaging, 34, pp.729~749 (2011)
- Larson SP, "Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass", Clin Gastroenterol Hepatol, 5, pp.1329~1332 (2007)
- Bonekamp S, "Spatial distribution of MRI-determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease", J Magn Reson Imaging, 39, pp.1525~1532 (2014)
- Campo CA, "Standardized approach for ROI-based measurements of proton density fat fraction and R2* in the liver", AJR Am J Roentgenol, 209, pp.592~603 (2017)
- Tang A, "Nonalcoholic fatty liver disease : MR imaging of liver proton density fat fraction to assess hepatic steatosis", Radiology, 267, pp.422~431 (2013)
- Hines CD, "T1 independent, T2*corrected chemical shift based fat–water separation with multipeak fat spectral modeling is an accurate and precise measure of hepatic steatosis", J Magn Reson Imaging, 33, pp.873~881 (2011)
- Bastati N, "Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid–enhanced MR imaging in patients with nonalcoholic fatty liver disease : a proof-of-concept study", Radiology, 271, pp.739~747 (2014)
- Stocker D, "Accuracy of automated liver contouring, fat fraction, and R2* measurement on gradient multiecho magnetic resonance images", J Comput Assist Tomogr, 42, pp.697~706 (2018)
- Wang K, "Automated CT and MRI liver segmentation and biometry using a generalized convolutional neural network", Radiol Artif Intell, 1, pp.180022~ (2019)
- Zhang QH, "Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease : comparison with a region of interest sampling method", Quant Imaging Med Surg, 11, pp.2933~2942 (2021)
- Vu KN, "MRI-determined liver proton density fat fraction, with MRS validation : comparison of regions of interest sampling methods in patients with type 2 diabetes", J Magn Reson Imaging, 43, pp.1090~1099 (2016)
- Hong CW, "Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification", J Magn Reson Imaging, 47, pp.988~994 (2018)
- Procter AJ, "Measuring liver fat fraction with complex-based chemical shift MRI : the effect of simplified sampling protocols on accuracy", BMC Med Imaging, 19, pp.14~ (2019)